Why the conversation around anti-amyloid therapies matters
Recent headlines have reignited debate around anti-amyloid therapies for Alzheimer’s disease, following commentary around a review questioning whether these treatments provide meaningful benefit for people living with dementia. ReMind UK’s Research & Medical Director, Dr Tomas Welsh, responds to the debate.
How dementia research is making a real difference for carers: John’s story
When John Desmond’s wife, Linda, was diagnosed with semantic dementia in 2021 at the age of 67, it marked the beginning of a new chapter for them both. Semantic dementia, a form of frontotemporal dementia, affects a person’s ability to use and understand words.
Transforming dementia diagnosis through blood test research
A recent BBC News article highlights a groundbreaking trial exploring how new and existing blood tests could transform the way dementia is diagnosed in the UK.